Lilly’s Next-Gen Weight Loss Shot Cuts Body Weight by 28% in Study

Nearly half of patients who got a high dose of Eli Lilly’s experimental obesity shot retatrutide lost the equivalent weight of bariatric surgery, sending the drugmaker’s shares up in premarket trading.